共 50 条
- [1] Phase III trial of lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone in newly diagnosed multiple myeloma (E4A03): A trial coordinated by the Eastern Cooperative Oncology GroupJOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)Rajkumar, S. V.Jacobus, S.Callander, N.Fonseca, R.Vesole, D.Williams, M.Abonour, R.Siegel, D.Greipp, P.
- [2] A randomized trial of lenalidomide plus high-dose dexamethasone (RD) versus lenalidomide plus low-dose dexamethasone (Rd) in newly diagnosed multiple myeloma (E4A03): A trial coordinated by the eastern cooperative oncology groupBLOOD, 2007, 110 (11) : 31A - 31ARajkumar, S. VincentJacobus, SusannaCallander, NatalieFonseca, RafaelVesole, DavidWilliams, MichaelAbonour, RafatSiegel, DavidGreipp, Philip
- [3] Phase III trial of thalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone in newly diagnosed multiple myelomaCLINICAL LYMPHOMA & MYELOMA, 2007, 7 (07): : 452 - 453不详
- [4] Randomized trial of lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone in newly diagnosed myeloma (E4A03), a trial coordinated by the Eastern Cooperative Oncology Group: Analysis of response, survival, and outcome wiJOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)Rajkumar, S. V.Jacobus, S.Callander, N.Fonseca, R.Vesole, D.Williams, M. V.Abonour, R.Siegel, D. S.Katz, M.Greipp, P. R.
- [5] Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone: Results of the phase III E4A03 trial for newly diagnosed patientsCLINICAL LYMPHOMA & MYELOMA, 2008, 8 (01): : 17 - 18Muneer, SabeehaCunningham, Sonia
- [6] Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trialLANCET ONCOLOGY, 2010, 11 (01): : 29 - 37Rajkumar, S. VincentJacobus, SusannaCallander, Natalie S.Fonseca, RafaelVesole, David H.Williams, Michael E.Abonour, RafatSiegel, David S.Katz, MichaelGreipp, Philip R.
- [7] Effect of Venous Thrombotic Events on Overall Survival in Multiple Myeloma: Analysis of Thrombotic Events Occurring in E4A03A Randomized Trial of Lenalidomide Plus High-Dose Dexamethasone (RD) Versus Lenalidomide Plus Low-Dose Dexamethasone (Rd) in Newly Diagnosed Multiple Myeloma, a Trial Coordinated by the Eastern Cooperative Oncology Group (ECOG).BLOOD, 2008, 112 (11) : 613 - 614Jacobus, SusannaKumar, ShajiCallander, Natalie ScottAbonour, RafatFonseca, RafaelSiegel, DavidGreipp, PhilipRajkumar, S. Vincent
- [8] Thalidomide plus dexamethasone versus dexamethasone alone in newly diagnosed multiple myeloma (E1AOO): Results of a phase III trial coordinated by the eastern cooperative oncology group.BLOOD, 2004, 104 (11) : 63A - 63ARajkumar, SVBlood, EVesole, DHShepard, RGreipp, PR
- [9] A randomised phase III trial of thalidomide plus dexamethasone versus dexamethasone in newly diagnosed multiple myeloma (E1AOO): Atrial coordinated by the Eastern Cooperative Oncology Group.JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 560S - 560SRajkumar, SVBlood, EVesole, DHShepard, RGreipp, PR
- [10] Primary Therapy with Lenalidomide plus Low-Dose Dexamethasone Versus High-Dose Dexamethasone: Update of the E4A03 TrialCLINICAL LYMPHOMA & MYELOMA, 2009, 9 (02): : 125 - 126不详